| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_057f2afd4fd74406b308f374588feb5d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d21cbff64022f95c237c0bd3ec8656ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9abfdee2fc9cf57318bae828d0b9ed2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d652b1f401491a477a327a5d3e01ec2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_61f88efcda59d7062a4252ecf6886f58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4567b3022b3e6844315fb74b586ca553 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-44 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
1998-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1228050077c57f490838b2c22b9683a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f5618074b2d8e7116e216688f6efe01a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_992de0f62c804954306351b9508b9cec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9825cedbdacb604cef2246c5d05515b |
| publicationDate |
1998-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9830577-A1 |
| titleOfInvention |
RECOMBINANT HUMAN IgA-J. CHAIN DIMER |
| abstract |
Disclosed are compositions and methods of use that comprise engineered IgA antibodies that, when administered to a host are secreted across the epithelium into the mucosal barriers of the body providing external passive immunotherapy against agents such as viral, bacterial and eukaryotic pathogens. Also disclosed are mini antibodies comprising the minimal transcytosis domains. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022073066-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637638-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8133486-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8114404-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6911204-B2 |
| priorityDate |
1997-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |